GUIDED THERAPEUTICS INC Quarterly Depreciation in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Guided Therapeutics Inc quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
  • Guided Therapeutics Inc Depreciation for the quarter ending March 31, 2024 was $2K, unchanged year-over-year.
  • Guided Therapeutics Inc annual Depreciation for 2023 was $9K, a 125% increase from 2022.
  • Guided Therapeutics Inc annual Depreciation for 2022 was $4K, a 300% increase from 2021.
  • Guided Therapeutics Inc annual Depreciation for 2021 was $1K.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $2K +$2K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2015 $72K -$45K -38.5% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-13
Q1 2014 $117K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.